The U.S. Food and Drug Administration has imposed an import ban on products made at Dr. Reddy's Laboratories Ltd.'s (500124.BY) Mexico unit for violation of manufacturing practice rules, the regulator's website showed Wednesday. The FDA had last month sent a warning letter to the Indian generic drug maker, specifying four deviations at the facility of the Industrias Quimicas Falcon de Mexico SA de C.V. unit. It had asked Dr. Reddy's to determine their cause and prevent them from recurring.
